Biorestorative Therapies, Inc. (BRTX)

Last Closing Price: 1.45 (2024-02-20)

Company Description

BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols, primarily involving adult stem cells. The company's core programs consist of Disc/Spine Program and Metabolic Program. Disc/Spine Program consists of cell therapy candidate, brtxDISC(TM) is a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow. Metabolic Program consists of ThermoStem(R), developing an allogeneic cell-based therapy to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. BioRestorative Therapies, Inc. is based in Melville, New York.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $0.12M
Net Income (Most Recent Fiscal Year) $-18.50M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) 53.66
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 0.54
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) -12194.34%
Net Margin (Trailing 12 Months) -12195.10%
Return on Equity (Trailing 12 Months) -117.00%
Return on Assets (Trailing 12 Months) -110.65%
Current Ratio (Most Recent Fiscal Quarter) 13.51
Quick Ratio (Most Recent Fiscal Quarter) 13.51
Debt to Common Equity (Most Recent Fiscal Quarter) 0.00
Inventory Turnover (Trailing 12 Months) --
Book Value per Share (Most Recent Fiscal Quarter) $4.34
Earnings per Share (Most Recent Fiscal Quarter) $-0.64
Earnings per Share (Most Recent Fiscal Year) --
Diluted Earnings per Share (Trailing 12 Months) --
Stock
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Common Shares Outstanding 4.71M
Free Float 3.69M
Market Capitalization $7.01M
Average Volume (Last 20 Days) 1.35M
Beta (Past 60 Months) 62.72
Percentage Held By Insiders (Latest Annual Proxy Report) 21.60%
Percentage Held By Institutions (Latest 13F Reports) 6.93%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%